Tag:#Medicinal Cannabis

Apollon Establishes The ‘Apollon Kannabiz Cooperative’ To Work With Over A Dozen Jamaican Cultivators 


Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased...

Cannabis-Cautious Financial Regulators Delay UK Cultivator’s London Stock Exchange Plans

HELLENIC Dynamics, set to become the first ever cannabis cultivation company to list on the London Stock Exchange (LSE), is now planning to launch...

Danish Biotech Firm Secures €2m Funding To Support Its Pharma-Focused Medical Cannabis Vision

TETRA Pharm has successfully completed its first external funding round raising €2m in capital to help it launch clinical trials and expand its operations...

Will 2022 Be The Year When A Maturing European Cannabis Industry Becomes Mainstream?

FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022. While there may have been a...

2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models

Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities...

A Ground-Breaking Year For European Cannabis Mapped Out In BusinessCann’s 2021 Top 10

THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into the post-prohibition era. Top of...

German Pharmaceutical Firm Enters Cannabis Space With Purchase Of Canopy Growth European Asset

FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group. C³ specialises...

After Securing Cultivation Licence Guernsey-Based 4C Labs Will Open UK Medical Cannabis Tele-Clinics

4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch virtual health clinics in...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read